Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP923471.RA5_mbSzXpMNDUEvq32UMpB_xfuyh-IBaWmHexxRSb3y0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP923471.RA5_mbSzXpMNDUEvq32UMpB_xfuyh-IBaWmHexxRSb3y0130_assertion type Assertion NP923471.RA5_mbSzXpMNDUEvq32UMpB_xfuyh-IBaWmHexxRSb3y0130_head.
- NP923471.RA5_mbSzXpMNDUEvq32UMpB_xfuyh-IBaWmHexxRSb3y0130_assertion description "[Combination of NPM-ALK repression and CD30 ligand leads to significantly increased tumor cell growth inhibition compared with one method alone, suggesting its potential application for ALCL-specific cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP923471.RA5_mbSzXpMNDUEvq32UMpB_xfuyh-IBaWmHexxRSb3y0130_provenance.
- NP923471.RA5_mbSzXpMNDUEvq32UMpB_xfuyh-IBaWmHexxRSb3y0130_assertion evidence source_evidence_literature NP923471.RA5_mbSzXpMNDUEvq32UMpB_xfuyh-IBaWmHexxRSb3y0130_provenance.
- NP923471.RA5_mbSzXpMNDUEvq32UMpB_xfuyh-IBaWmHexxRSb3y0130_assertion SIO_000772 16982741 NP923471.RA5_mbSzXpMNDUEvq32UMpB_xfuyh-IBaWmHexxRSb3y0130_provenance.
- NP923471.RA5_mbSzXpMNDUEvq32UMpB_xfuyh-IBaWmHexxRSb3y0130_assertion wasDerivedFrom befree-20140225 NP923471.RA5_mbSzXpMNDUEvq32UMpB_xfuyh-IBaWmHexxRSb3y0130_provenance.
- NP923471.RA5_mbSzXpMNDUEvq32UMpB_xfuyh-IBaWmHexxRSb3y0130_assertion wasGeneratedBy ECO_0000203 NP923471.RA5_mbSzXpMNDUEvq32UMpB_xfuyh-IBaWmHexxRSb3y0130_provenance.